8-K
filed April 8, 2022, 7:59 PM ET
ticker ENOV
CIK 0001420800
M&A
confidence high
sentiment neutral
materiality 0.85
Enovis completes ESAB spin-off; new $1.8B credit facility; board refreshed
Enovis CORP
- On April 4, 2022, Enovis distributed 90% of ESAB shares: 1 ESAB per 3 Enovis shares; retained 10%.
- Enovis entered new $900M revolver and $900M term loan; repaid prior debt and funds general corporate purposes.
- On April 7, Enovis redeemed €350M 3.25% notes due 2025 and $300M 6.375% notes due 2026 with Separation proceeds.
- Directors Allender, Jordan, Teirlinck resigned to ESAB board; Bodem, Lalor, Ortiz, Shirley appointed to Enovis board.
- Name changed from Colfax to Enovis; 1-for-3 reverse stock split effected; stock trades under ENOV as of April 5.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patrick W. Allender resigned as Director at Enovis CORP.
- Action
- resigned
- Role
- Director
Exact text from the filing
On April 4, 2022, effective upon consummation of the Separation, each of Patrick W. Allender, Rhonda L. Jordan and Didier Teirlinck resigned from the board of directors of the Company (the “ Board ”) to serve on the board of directors of ESAB.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas S. Gayner resigned as Director at Enovis CORP.
- Action
- resigned
- Role
- Director
Exact text from the filing
Also, as previously announced, on March 31, 2022, Thomas S. Gayner resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brady R. Shirley was appointed as Director at Enovis CORP.
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the vacancies created by the director resignations and retirement, on April 4, 2022, effective upon consummation of the Separation, each of Barbara W. Bodem, Angela S. Lalor, Dr. Christine Ortiz and Brady R. Shirley were appointed by the Board to serve as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Christine Ortiz was appointed as Director at Enovis CORP.
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the vacancies created by the director resignations and retirement, on April 4, 2022, effective upon consummation of the Separation, each of Barbara W. Bodem, Angela S. Lalor, Dr. Christine Ortiz and Brady R. Shirley were appointed by the Board to serve as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Rhonda L. Jordan resigned as Director at Enovis CORP.
- Action
- resigned
- Role
- Director
Exact text from the filing
On April 4, 2022, effective upon consummation of the Separation, each of Patrick W. Allender, Rhonda L. Jordan and Didier Teirlinck resigned from the board of directors of the Company (the “ Board ”) to serve on the board of directors of ESAB.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Didier Teirlinck resigned as Director at Enovis CORP.
- Action
- resigned
- Role
- Director
Exact text from the filing
On April 4, 2022, effective upon consummation of the Separation, each of Patrick W. Allender, Rhonda L. Jordan and Didier Teirlinck resigned from the board of directors of the Company (the “ Board ”) to serve on the board of directors of ESAB.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Barbara W. Bodem was appointed as Director at Enovis CORP.
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the vacancies created by the director resignations and retirement, on April 4, 2022, effective upon consummation of the Separation, each of Barbara W. Bodem, Angela S. Lalor, Dr. Christine Ortiz and Brady R. Shirley were appointed by the Board to serve as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Angela S. Lalor was appointed as Director at Enovis CORP.
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the vacancies created by the director resignations and retirement, on April 4, 2022, effective upon consummation of the Separation, each of Barbara W. Bodem, Angela S. Lalor, Dr. Christine Ortiz and Brady R. Shirley were appointed by the Board to serve as directors of the Company.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.